May 13, 2025
JFP Limited (JFP)
Unaudited financials for the first quarter ended March 31, 2025:
JFP Limited (JFP) for the first quarter ended March 31, 2025, reported a 30% decrease in revenue totalling $112.24 million compared to $159.82 million in the corresponding three months last year.
Cost of Sales amounted to $52.78 million (2024: $97.96 million), this represents a decrease of 46% year over year. Consequently, gross profit decreased by 4% to $59.46 million compared to $61.86 million for the first quarter ended March 31, 2024.
Other Income increased by 148% to close at $455,256 (2024: Other losses $945,743), while Administrative Expenses decreased from $52.00 million in 2024 to $51.76 million for the three months. As a result, total operating expenses for the first quarter amounted to $54.32 million, a 1% decrease relative to $54.94 million reported in 2024.
Operating Profit for the three months amounted to $5.59 million, a 6% decrease relative to $5.97 million reported in 2024.
Net Finance cost totalled $5.12 million, a 136% increase from the corresponding period last year. (2024: $2.17 million).
No taxes were incurred. As such, Net Profit for the three months had a 88% decrease to reach $474,601 (2024: $3.80 million).
Consequently, Earnings Per Share for the three months amounted to $0.0004 (2024: EPS: $0.0034). The twelve-month trailing LPS was $0.11, and the number of shares used in these calculations was 1,120,000,000.
Notably, JFP’s stock price closed the trading period on May 13, 2025, at a price of $0.59.
Balance Sheet Highlights
The company’s assets totalled $595.79 million (2024: $535.33 million). The movement in total assets was influenced by increases in PPE and inventories, but was however offset somewhat by a downturn in investments.
Shareholder’s equity was $28.03 million (2024: $137.22 million), representing a book value per share of $0.03 (2024: $0.12).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.